Evidence map›Paper›PMID 22249124›Full record

ArticleBioorganic & medicinal chemistry2012

Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.

Kok-Chuan Tiew, Dengfeng Dou, Tadahisa Teramoto, Huiguo Lai, Kevin R Alliston, Gerald H Lushington, R Padmanabhan, William C Groutas

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Targeting the protease of West Nile virus.RSC medicinal chemistry · 2021
    Review
  4. Facile Synthesis and In Vitro Activity ofPathogens (Basel, Switzerland) · 2021
    Article
  5. Article
  6. Co-cultivation ofFrontiers in microbiology · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Kok-Chuan TiewDepartment of Chemistry, Wichita State University, Wichita, KS 67260, USA.
Dengfeng Dou
Tadahisa Teramoto
Huiguo Lai
Kevin R Alliston
Gerald H Lushington
R Padmanabhan
William C Groutas
Wichita State University · USGeorgetown University Medical Center · USGeorgetown University · USUniversity of Kansas · US

Funding

UNDERSTANDING THE ROLE OF SMALL RNAS IN ARABIDOPSIS POLLEN DEVELOPMENTP20RR016475 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ACKLEY, BRIAN DOUGLAS · 2001 to 2011
$38.1M
Development of Antiviral Therapeutics for Dengue: Inhibitors of Viral ProteaseU01AI082068 · NIAID · GEORGETOWN UNIVERSITY · PI PADMANABHAN, RADHAKRISHNAN · 2009 to 2010
$1.2M
NCRR NIH HHS P20 RR016475NIAID NIH HHS AI082068NIAID NIH HHS U01 AI082068
6 · The paper itself

Abstract

Two click chemistry-derived focused libraries based on the benz[d]isothiazol-3(2H)-one scaffold were synthesized and screened against Dengue virus and West Nile virus NS2B-NS3 proteases. Several compounds (4l, 7j-n) displayed noteworthy inhibitory activity toward Dengue virus NS2B-NS3 protease in the absence and presence of added detergent. These compounds could potentially serve as a launching pad for a hit-to-lead optimization campaign.

Indexed as

Antiviral AgentsClick ChemistryDengueDengue VirusHumansModels, MolecularPeptide HydrolasesProtease InhibitorsThiazolesWest Nile FeverWest Nile virusAntiviral AgentsPeptide HydrolasesProtease InhibitorsThiazoles

Identifiers

PMID22249124
PMCPMC3279297
OpenAlexW1965990604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.